Table 2 Baseline characteristics of all patients in the training cohort and validation cohort
From: Prediction nomogram for coronary artery aneurysms at one month in Kawasaki disease
Levels | Development cohort | Validation cohort | P | |
|---|---|---|---|---|
Number | 599 | 370 | - | |
Sex, n (%) | Females | 227 (37.9) | 158 (42.7) | 0.156 |
Males | 372 (62.1) | 212 (57.3) | ||
Age, months, (mean (SD)) | 19.0 [11.0, 37.0] | 26.0 [14.0, 45.0] | < 0.001 | |
Age, months, n (%) | < 12 | 153 (25.5) | 60 (16.2) | 0.008 |
≥ 12 and < 36 | 284 (47.4) | 182 (49.2) | ||
≥ 36 and < 60 | 103 (17.2) | 84 (22.7) | ||
≥ 60 and < 120 | 56 ( 9.3) | 42 (11.4) | ||
≥ 120 | 3 ( 0.5) | 2 ( 0.5) | ||
Complete KD, n (%) | No | 110 (18.4) | 67 (18.1) | 0.988 |
Yes | 489 (81.6) | 303 (81.9) | ||
Use of IVIG, n (%) | No | 5 ( 0.8) | 8 ( 2.2) | 0.145 |
Yes | 594 (99.2) | 362 (97.8) | ||
Days of IVIG at initiation, (mean (SD)) | 7.00 (2.25) | 7.35 (2.06) | 0.019 | |
Days of IVIG initiation, n (%) | < 5 | 33 ( 5.5) | 14 ( 3.9) | 0.201 |
≥ 5 and< 8 | 367 (61.3) | 205 (56.6) | ||
≥ 8 and< 10 | 139 (23.2) | 98 (27.1) | ||
≥ 10 | 60 (10.0) | 45 (12.4) | ||
Total fever duration, days, (mean (SD)) | 7.43 (2.47) | 7.74 (2.26) | 0.056 | |
IVIG resistance, n (%) | No | 564 (94.2) | 340 (91.9) | 0.216 |
Yes | 35 ( 5.8) | 30 ( 8.1) | ||
CALs in the acute stage, n (%) | No | 449 (75.0) | 248 (67.0) | 0.008 |
Yes | 150 (25.0) | 122 (33.0) | ||